AR068514A1 - Aztreonam lisina inhalada para el tratamiento de deficits de salud relacionados con la calidad de vida (cvrs) de las enfermedades pulmonares - Google Patents
Aztreonam lisina inhalada para el tratamiento de deficits de salud relacionados con la calidad de vida (cvrs) de las enfermedades pulmonaresInfo
- Publication number
- AR068514A1 AR068514A1 ARP080104006A ARP080104006A AR068514A1 AR 068514 A1 AR068514 A1 AR 068514A1 AR P080104006 A ARP080104006 A AR P080104006A AR P080104006 A ARP080104006 A AR P080104006A AR 068514 A1 AR068514 A1 AR 068514A1
- Authority
- AR
- Argentina
- Prior art keywords
- quality
- treatment
- life
- lisina
- hrqol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Reivindicacion 1: El uso de una cantidad terapéuticamente efectiva de un polvo seco o aerosol inhalable, que comprende aproximadamente 1 a aproximadamente 250 mg de aztreonam usina por dosis individual en la elaboracion de un medicamento para el tratamiento de por lo menos un síntoma de calidad de vida relacionado con la salud de una enfermedad pulmonar en un paciente que lo necesita, donde dicho polvo seco o aerosol inhalable es administrado a las vías aéreas del pulmon utilizando un régimen de dosificacion que comprende la administracion de dicho polvo seco o aerosol inhalable durante por lo menos 14 a 28 días consecutivos seguidos por un período de 14 a 28 días de descanso del fármaco y la repeticion del régimen por lo menos una vez.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99707107P | 2007-10-01 | 2007-10-01 | |
| US99707207P | 2007-10-01 | 2007-10-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR068514A1 true AR068514A1 (es) | 2009-11-18 |
Family
ID=40032482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080104006A AR068514A1 (es) | 2007-10-01 | 2008-09-15 | Aztreonam lisina inhalada para el tratamiento de deficits de salud relacionados con la calidad de vida (cvrs) de las enfermedades pulmonares |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7973029B2 (es) |
| EP (1) | EP2200608A1 (es) |
| JP (1) | JP2010540539A (es) |
| KR (1) | KR20100093037A (es) |
| CN (1) | CN101951906A (es) |
| AR (1) | AR068514A1 (es) |
| AU (1) | AU2008307268A1 (es) |
| BR (1) | BRPI0817636A2 (es) |
| CA (1) | CA2701118A1 (es) |
| EA (1) | EA201070336A1 (es) |
| IL (1) | IL204593A0 (es) |
| MX (1) | MX2010003618A (es) |
| NZ (1) | NZ584269A (es) |
| TW (1) | TW200927193A (es) |
| WO (1) | WO2009045706A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214364B2 (en) | 2000-12-27 | 2007-05-08 | Corus Pharma, Inc. | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| DK1353647T3 (da) | 2000-12-27 | 2011-06-14 | Gilead Sciences Inc | Inhalerbar aztreonam til behandling og forebyggelse af bakterielle lungeinfektioner |
| CN104784159A (zh) * | 2015-04-15 | 2015-07-22 | 苏州惠仁生物科技有限公司 | 氨曲南粉雾剂的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5152456A (en) | 1989-12-12 | 1992-10-06 | Bespak, Plc | Dispensing apparatus having a perforate outlet member and a vibrating device |
| EP0615470B1 (en) | 1991-12-04 | 1995-12-13 | The Technology Partnership Public Limited Company | Fluid droplet production apparatus and method |
| DE19953317C1 (de) | 1999-11-05 | 2001-02-01 | Pari Gmbh | Inhalationsvernebler |
| US6962151B1 (en) | 1999-11-05 | 2005-11-08 | Pari GmbH Spezialisten für effektive Inhalation | Inhalation nebulizer |
| US7138419B2 (en) | 2000-12-27 | 2006-11-21 | Corus Pharma, Inc. | Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate |
| US7214364B2 (en) | 2000-12-27 | 2007-05-08 | Corus Pharma, Inc. | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| DK1353647T3 (da) | 2000-12-27 | 2011-06-14 | Gilead Sciences Inc | Inhalerbar aztreonam til behandling og forebyggelse af bakterielle lungeinfektioner |
| DE10102846B4 (de) | 2001-01-23 | 2012-04-12 | Pari Pharma Gmbh | Aerosolgenerator |
-
2008
- 2008-09-15 WO PCT/US2008/076431 patent/WO2009045706A1/en active Application Filing
- 2008-09-15 JP JP2010527021A patent/JP2010540539A/ja active Pending
- 2008-09-15 KR KR1020107009839A patent/KR20100093037A/ko not_active Application Discontinuation
- 2008-09-15 BR BRPI0817636A patent/BRPI0817636A2/pt not_active IP Right Cessation
- 2008-09-15 US US12/210,965 patent/US7973029B2/en not_active Expired - Fee Related
- 2008-09-15 EP EP08836327A patent/EP2200608A1/en not_active Withdrawn
- 2008-09-15 CA CA2701118A patent/CA2701118A1/en not_active Abandoned
- 2008-09-15 AR ARP080104006A patent/AR068514A1/es not_active Application Discontinuation
- 2008-09-15 MX MX2010003618A patent/MX2010003618A/es not_active Application Discontinuation
- 2008-09-15 AU AU2008307268A patent/AU2008307268A1/en not_active Abandoned
- 2008-09-15 EA EA201070336A patent/EA201070336A1/ru unknown
- 2008-09-15 CN CN2008801170106A patent/CN101951906A/zh active Pending
- 2008-09-15 TW TW097135359A patent/TW200927193A/zh unknown
- 2008-09-15 NZ NZ584269A patent/NZ584269A/en not_active IP Right Cessation
-
2010
- 2010-03-18 IL IL204593A patent/IL204593A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009045706A1 (en) | 2009-04-09 |
| BRPI0817636A2 (pt) | 2019-09-24 |
| MX2010003618A (es) | 2010-04-21 |
| AU2008307268A1 (en) | 2009-04-09 |
| IL204593A0 (en) | 2010-11-30 |
| EP2200608A1 (en) | 2010-06-30 |
| US7973029B2 (en) | 2011-07-05 |
| EA201070336A1 (ru) | 2011-06-30 |
| US20090124594A1 (en) | 2009-05-14 |
| KR20100093037A (ko) | 2010-08-24 |
| TW200927193A (en) | 2009-07-01 |
| CN101951906A (zh) | 2011-01-19 |
| NZ584269A (en) | 2012-06-29 |
| CA2701118A1 (en) | 2009-04-09 |
| JP2010540539A (ja) | 2010-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090197941A1 (en) | Pharmaceutical Compositons for the Treatment of Chronic Obstructive Pulmonary Disease | |
| EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| AR040682A1 (es) | Forma de dosificacion una vez al dia de pramipexol | |
| CO6361944A2 (es) | Combinacion de una insulina y un agonista de glp-1 | |
| ES2369547T8 (es) | Procedimiento para el tratamiento de enfermedades humanas asociadas con un contenido elevado de ácido desoxirribonucleico en los espacios extracelulares de los tejidos y preparación médica para llevar a cabo dicho procedimiento. | |
| AR045289A1 (es) | Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento | |
| JP2010526837A5 (es) | ||
| US20220387455A1 (en) | Treatment of moderate to severe influenza | |
| UY31418A1 (es) | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos | |
| JP2020179191A (ja) | 経鼻投与 | |
| AR068514A1 (es) | Aztreonam lisina inhalada para el tratamiento de deficits de salud relacionados con la calidad de vida (cvrs) de las enfermedades pulmonares | |
| JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 | |
| JP2020536121A5 (es) | ||
| JP2016510040A5 (es) | ||
| Sanders et al. | Prolonged suppression of cough after inhalation of lidocaine in a patient with sarcoid | |
| AR047154A1 (es) | Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol | |
| EP3906934A1 (en) | Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections | |
| Kalaivani | Methamphetamine substance abuse and Dental Considerations: a modern era crisis | |
| CN114767664A (zh) | 一种用于治疗新型冠状病毒的干粉状药物 | |
| JP2006508993A5 (es) | ||
| Van Wyk | The common cold and influenza: colds & flu | |
| JPWO2021211916A5 (es) | ||
| JP2021161105A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 | |
| JP2010519274A5 (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |